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Abstract
Background: The 3D structure and functions of ENPP4, a protein expressed on the surface of Bacillus Calmette–
Guerin (BCG)-activated macrophages, are unknown. In this study, we analyzed the 3D structure of ENPP4 and
determined its tumoricidal effects on MCA207 cells.
Results: Homology modeling showed that Arg305, Tyr341, Asn291, and Asn295 are important residues in
substrate, adenosine triphosphate (ATP), binding. A molecular dynamics study was also carried out to study the stability
of ENPP4 (including zinc atoms) as well as its ligand–enzyme complex. BCG increased ENPP4 expression in
macrophages, and specific blocking of ENPP4 in BCG-activated macrophages (BAMs) significantly reduced their
cytotoxicity against MCA207 cells.
Conclusions: These results indicate that zinc remains inside the ENPP4 protein, a BCG activated tumoricidal
macrophage protein, throughout the simulation. Important information for the design of new inhibitors was obtained.
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Background
Macrophages are the first line of defense of the human
body against cancer development. Bacillus Calmette–
Guerin (BCG) is a highly effective mediator that initiates
the tumoricidal effect of macrophages through direct
contact [1–5]. However, the mechanism of the antitumor
effects of BCG remains unknown.
BCG can bind with TLR2 and TLR4 and upregulate
certain proteins expressed on the macrophage surface or
secreted to the microenvironment [6]. Activated macro-
phages can secrete large amounts of pro-inflammatory
cytokines, such as tumor necrosis factor-α(TNF-α) and
interlukine-12(IL-12), Nitric oxide(NO), reactive oxygen
intermediates and highly express MHC-II and the costimu-
latory molecules CD80 and CD86 [7]. These molecules
contribute to the tumoricidal effects of macrophages. Aside
from these molecules [8], other membrane proteins
involved in anti-tumor activities have been found to exist
on the surface of BCG-activated macrophage (BAMs), as
proven by the LS-LSM/MS technique.
Ectonucleotide pyrophosphatase–phosphodiesterases 4
(ENPP4) is an upregulated protein expressed on the BAM
surface [2, 3]. However, its functions are incompletely
understood. The nucleotide pyrophosphatase–phospho-
diesterase or ectonucleotide pyrophosphatase–phospho-
diesterase family includes eight members (NPP1–NPP8 or
ENPP1–ENPP8) [9–11]. ENPP1–ENPP3 are composed of
two N-terminal somatomedin B (SMB)-like domains
(SMB1 and SMB2), a catalytic domain, and a nuclease-like
domain (ENPP3 is monomeric). These phosphodiesterases
are type-2 transmembrane metalloenzymes and have a
short intracellular N-terminus, a single transmembrane
region, and an extracellular domain that contains a
catalytic site. By contrast, members ENPP4–ENPP7
consist of a single catalytic domain. Isoforms ENPP4
and ENPP5 are type-1 transmembrane proteins with a
short intracellular C-terminus and a small extracellular
region that contains only a phosphodiesterase motif.
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The related physiological and pathological roles of ENPP
family members, including their regulation of extracellular
pyrophosphate levels, cell motility, migration, angiogenesis,
and tumor cell invasion, have recently become the focus of
intensive research [12–15]. The isozyme ENPP1 catalyzes
nucleotides that generate pyrophosphate, which can pre-
vent excessive bone calcification. The subtype ENPP2 (or
autotaxin) hydrolyzes lysophosphatidylcholine into lyso-
phosphatidic acid and is involved in vasculature and neural
tube formation and lymphocyte migration [12]. The en-
zyme ENPP3 (CD203) is a basophile marker [13] with a
glycosylated type II transmembrane structure. ENPP5 has
not been widely studied, but its closely related molecule,
ENPP2, has been widely implicated in neoplasia and exten-
sively studied in efforts to develop small-molecule inhibi-
tors [14]. In fact, ENPP2 has been identified as a novel
angiogenesis-associated gene [15]. The isoform ENPP6 has
lysophospholipase-C activity for choline-containing glycer-
ophosphodiesters, and the isoform NPP7 has alkaline
sphingomyelinase activity and catalyzes lysophosphatidyl-
choline. No study on the structure and functions of ENPP8
has yet been reported. Although some studies have re-
ported the structure of ENPP4, its 3D structure and related
functions are largely unknown.
The present study aims to analyze the 3D structure
of ENPP4 on the BAM surface through molecular
modeling and study its tissue distribution and tumori-
cidal effects through immunohistochemistry.
Results
Homology modeling
The search for the best template for modeling ENPP4
was carried out using PSI-BLAST against PDB. ENPP1
(PDB code4GTX) [10] showed the best sequence simi-
larity with ENPP4 (39 %, Fig. 1). A phylogenetic tree of
ENPP4 and its closest related sequences was constructed
based on multiple sequence alignment (Fig. 2). This tree
showed that ENPP4 has one clade, the ENPP4 subfamily.
ENPP1 (PDB Id 4GTX) was selected as the template for
ENPP4 modeling studies.
The initial model of ENPP4 was generated using a
Swiss model. The initial model was refined by an energy
minimization protocol in Gromacs 4.5.1. The final
model was validated using four tools: Values of the root-
mean square deviation (RMSD) from the initial structure
were stable after approximately 2 ns (Additional file 1:
Figure S1); such stabilization indicates that the trajector-
ies have equilibrated. The final structure was further
evaluated by Procheck. Ramachandran plot showed that
the backbone dihedral angle distributions of all of the
amino acid residues were 84.3 % in the core region,
13.4 % in the allowed region, and 1.3 % in the generously
allowed region, as presented in Table 1. Meanwhile, the
template ENPP1 (PDB Id 4GTX) presented 88.7 % in
the core region and 11.3 % in the allowed region. These
results indicate that the backbone dihedral angles of the
ENPP4 model are reasonably accurate. The ERRAT
Fig. 1 Sequence alignment of ENPP4 with other ENPP proteins. ENPP4 has 39 % sequence identity with PDB Id 4GTX (ENPP1) and 34 %
sequence identity with PDB Id2XR9 (ENPP1)
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score for ENPP4 was 86.36, whereas that for the tem-
plate was 88.53 (Table 1); these scores are very similar.
The final conformation with the lowest energy was
chosen. Comparison of the model of the 3D structure of
ENPP4 and the crystal structure of ENPP1 showed simi-
lar distributions of secondary structures (Fig. 3). The 3D
structure supermposed between the ENPP1 and ENPP4
was 0.13 Å.
All of these findings indicate that the 3D structure of
ENPP4 obtained by MD simulation is reasonable and
can be used for further investigations.
Docking study
ENPP family proteins are membrane-bound glycopro-
teins. ENPP1 has been reported to cause human diseases
characterized by ectopic calcification [16]. ENPP2 is a
secreted lysophospholipase D that hydrolyzes lysopho-
sphatidylcholine to produce lysophosphatidic acid (LPA),
which, in turn, activates G protein-coupled receptors to
evoke various cellular responses [17]. The five other
mammalian ENPP proteins, ENPP3–ENPP7, have dis-
tinct substrate specificities and tissue distributions and
thus participate in different biological processes. How-
ever, the 3D structure and biological functions of ENPP4
remain unknown.
ENPP1–ENPP3 are composed of two N-terminal SMB-
like domains (SMB1 and SMB2), a catalytic domain, and a
nuclease-like domain, whereas ENPP4–ENPP7 consist of
a catalytic domain and lack the SMB-like and nuclease-
like domains [16]. To determine the binding site between
the protein and the substrate, the cavity volume was esti-
mated by CASTp as a function of the radius of the probe
sphere. A probe radius of 1.4 A outlined a cavity of
2237.4 Å3 for ENPP4 (Additional file 2: Figure S2A) and a
cavity of 1177.7 Å3 for ENPP1 (Additional file 2: Figure
S2B). The active pockets of ENPP4 and the template were
similar. The active residues in ENPP1 were Asp358,
His362, His517, Asp200, Thr238, Asp405, and His406. In
ENPP4, Asp192, His196, His339 Asp37, Thr73, Asp240,
and His241 were located in the catalytic domain. The re-
constructed structure of ENPP4 reveals that the insertion
loop (residues 139–158) participates in the formation of
the substrate-binding pocket. In particular, M155 and
S158 are located on the protein surface, whereas P140 and
W138 are located at the bottom of the active pocket. The
different binding pockets observed may influence the sub-
strate specificities of the two proteins.
The substrate, ATP, was docked in ENPP4. Figure 4a
shows the binding pose of ATP in ENPP4. The substrate
is located in the catalytic cleft and fits the binding
pocket well. The interactions of ATP in the active cleft
of ENPP4 are shown in Fig. 4b. Five hydrogen bonds
were observed between ATP and ENPP4. Figure 4b
shows that Arg305 forms two hydrogen bonds with
ATP. The OH group of Tyr341 produces a hydrogen
bond with ATP, and the adenosine group of ATP forms
two hydrogen bonds with Asn291 and Asn295. Asp342,
Tyr341, Arg305, Tyr297, Met294, Pro292, Asn291,
Asn295, Arg289, and Cys290 show electrostatic interac-
tions with ENPP4, whereas Pro303, Phe306, Val320,
Glu322, His293, and Lys288 show van der Waals inter-
actions with ENPP4. These results may be helpful in de-
signing future ATP analogue inhibitors. The ligand was
mainly stabilized by the hydrogen bonds determined
during our MD simulation. Arg305, Tyr341, Asn291,
and Asn295 allowed hydrogen-bonding with ENPP4.
Fig. 2 A phylogenetic tree of ENPP4 and related families
Table 1 The 3D models validation with Procheck, and Errat
Protein Procheck Errat
ENPP4 Ramachandran plot: 84.3 %
core 13.4 % allow 1.3 % gener
86.36
ENPP1 (PDB Id 4GTX) 88.7 % core 11.3 % allow 0.0 % gener 88.53
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Among these residues, only Tyr431, which is located
near the His339-coordinated Zn2+ in the ENPP4 family
(Fig. 1).
Construction of pET-28a–ENPP4 and expression of
recombined ENPP4 protein and its polyantibody
The DNA fragment with an expected size of 750 bp was
obtained by PCR and enzyme digestion with EcoRI and
XhoI, which demonstrates that the correct pET-28a–
ENPP4 plasmids were constructed (Fig. 5a and b). After
the pET-28a–ENPP4 recombinant plasmid was trans-
formed in E. coli Rosetta (DE3), the expression of
ENPP4 was detected and shown in Fig. 5c and d, (32 KD
MW protein). A large amount of recombinant ENPP4
protein was obtained in insoluble form. The resulting
protein showed a purity of over 90 %, as determined by
SDS-PAGE (Fig. 5c). Polyclonal antibodies were pro-
duced in rabbits. Figure 5d shows the high specificity of
the anti-ENPP4 polyclonal antibodies for binding to
ENPP4, as determined by Western blot detection.
Expression of ENPP4 in tissues
The expression of ENPP4 was detected in 12 tissue sam-
ples from a normal female C57BL/6 mouse. ENPP4 was
abundantly expressed in the spleen, stomach, and ovary
(Fig. 6). No expression was observed in the brain, lung,
kidney, thymus, liver, heart, uterus, and intestine. This
result indicates that ENPP4 is involved in biological
pathways related to immunity and reproduction.
Tumoricidal activity of ENPP4 in BAMs
To study the contact-dependent tumoricidal activity of
ENPP4, cytotoxicity assays were carried out using
paraformaldehyde-fixed macrophages. BAMs showed
prominent cytotoxicity against MCA207 cells and this
cytotoxic activities may be downregulated by blocking
ENPP4 (Fig. 7a). The negative control did not exhibit
cytotoxic effects. These results demonstrate that ENPP4
may be an essential functional molecule in the BAM-
mediated killing of MCA207 cells. Furthermore, cytotox-
icity experiment results showed that ENPP4 protein exerts
direct tumoricidal activities against MCA207 cells (Fig. 7b).
Discussion
MD simulation was employed to assess the stability of
the homology model and the ligand–enzyme complex.
In the homology model, we focused on the catalytic
site, particularly on the amino acids that coordinate
Zn2+ and the interactions between the metal and the
enzyme. MD simulation was used to analyze the
ENPP4–ATP complex and identify the possible bio-
active conformation of the molecule. The conformation
of ATP obtained from molecular docking and the
ENPP4 model were used as the starting point for the
simulation. The ligand was mainly stabilized by the
hydrogen bonds determined during our MD simulation.
Among Arg305, Tyr341, Asn291, and Asn295, only
Tyr431 was conserved in the ENPP4 family. These ob-
servations suggest that this specific residue is necessary
for the molecular evolution of the ENPP family. The
plot shows the distance between the H in the oxygen of
Tyr341 and ATP. Interestingly, the stable formation of
Fig. 4 a: the substrate in the active site. b: ENPP4 -ATP interactions
Fig. 3 Overlay similarity between the ENPP4 (green) and the
template ENPP1 (purple)
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a hydrogen bond between the ligand and Asp141 was
observed during the 10 ns MD simulation. This finding
suggests that the residue of the catalytic site can
stabilize interactions between OH and ATP; however,
other studies featuring longer simulations are necessary
to support this idea.
Mycobacterium bovis BCG is the most widely used
vaccine in the world. BCG generates a local immuno-
logical reaction that activates immune cells, including
polymorphonuclear and mononuclear cells, in bladder
tumors after BCG therapy [12]. The ENPP family has
been reported to be involved in various pathologies,
Fig. 5 a Analysis of ENPP4 cDNA sequence amplified by RT-PCR. b Enzyme restriction assay with restriction enzymes EcoRI and XhoI of pET-28a-
ENPP4 vector construction. Lanes 1 shows the digested plasmids with its expected sizes released from constructed DNA-vectors. Lanes 2 shows
the non-digested plasmids. c SDS gel electrophoretic patterns of recombinant ENPP4 after purification. Lanes 1–3: different concentration of
ENPP4 protein stained by Coomassie blue. d PVDF membrane of western blotting assay of ENPP4 purified protein (32KD)
Fig. 6 The expression of ENPP4 in different tissues, red arrow show abundant expression. Scoring was completed by a specialist pathologist and
a scientist who were blinded to the pathologic information (× 400)
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including tumor progression and inflammation. ENPP2
is a secreted lysophospholipase D that generates the lipid
mediator LPA, a mitogen, and a known chemoattractant
for many cell types [18]. We have certified that the ex-
pression of ENPP4 is upregulated by BCG (Additonal
file 3: Figure S3). Blocking ENPP4 on BAM significantly
downregulates the anti-tumor activity of the cell, which
demonstrates that ENPP4 has potential tumoricidal
activity.
ENPP4 showed a catalytic domain in Asp192, His196,
His339 Asp37, Thr73, Asp240, and His241, which sug-
gests that the ENPP4 may affect some receptor such as
ATP receptor or insulin receptor on the surface of
tumor cells to reduce their proliferation by indirectly or
directly contact, receptively [19, 20]. On the one hand,
ENPP4 may catalize the extracellular ATP released from
tumor cells and reduce the binding between ATP and
ATP receptor [19, 21], on the other hand, ENPP4 may
contact the insulin receptor and inhibit the insulin re-
ceptor activity [20, 22].
Altergether, ENPP4 may thus be targeted as a thera-
peutic molecule for treating tumors. To explore the
therapeutic potential of such a strategy, more detailed
knowledge of the functions of ENPP4 and its ligand in
tumor cells is needed.
Conclusion
Our findings provide novel insights into the structure of
ENPP4 and help researchers better understand its di-
verse cellular functions.
Methods
All experiments conform to Jilin University guidelines
on the ethical use of animals and were approved by the
Institutional Animal Care and Use Committee. The mice
used were C57BL/6 (wild-type, WT).
Homology modeling
The amino acid sequence of the target protein, ENPP4,
was obtained from the National Center for Biotechnol-
ogy Information NCBI (http://www.ncbi.nlm.nih.gov/)
(GenBank: NP_950181; template protein: ENPP1 (PDB
Id 4GTX) [16]. The BLAST search algorithm was used
for an online search (http://www.ncbi.nlm.nih.gov). A
modeler module was employed to build the 3D structure
of the protein. Modeling was then carried out using
Gromacs 4.5.1 software [23] with the Gromos53a6 all-
atom force field. The temperatures were kept constant
at T = 25 °C by coupling to a Berendsen thermostat with
a coupling time of T = 0.1 ps. The protein was solvated
using a box of TIP3P [24] water molecules extending at
least 10 Å away from the boundary of any protein atom
with an integration step of 2 fs. Non-bonded interactions
were calculated using a cutoff of 10 Å. Long-range elec-
trostatic interactions were calculated by Particle–Mesh
Ewald summation with a grid spacing of 1.2 Å and cubic
interpolation. After 1000 steps of steepest descent en-
ergy minimization, the solvent and ions were equili-
brated by 0.5 ns molecular dynamics (MD) simulation,
with the heavy protein atoms subjected to harmonic
constraints under a force constant of k = 1000 kcal/
(mol−1 · nm−2). Finally, a production run was carried
out for 10 ns, and the coordinates of all atoms at each
picosecond were stored for further analysis. In our
studies, CASTp (http://cast.engr.uic.edu/cast/) [25] was
used to identify all of the cavities associated with the
model and the template and measure their volumes.
The results obtained were further used for protein-
ligand docking investigations.
Docking study
The software AutoDock Vina [26, 27] was applied for
docking studies. The 3D structures of the substrate were
Fig. 7 ENPP4 has tumoricidal activity against MCA207 cells. a Antibodies against ENPP4 influenced the tumoricidal activity of macrophages.
Negative control cells exhibited no cytotoxic activity, whereas BCG-activated macrophages exhibited a cytotoxicity of 50 %. Blocking ENPP4
on BCG-activated macrophages decreased the cytotoxicity to 35.1 %. *, P < 0.05 compared with positive control. b ENPP4 protein inhibited the
proliferation of MCA207 cells in a dose-dependent manner. *, P < 0.05 compared with negative control
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downloaded from the Chemspider database. The target
used in our study was the 3D structure of ENPP4. The
grid size for docking measured 36 × 36 × 36 Å3.
Cloning of ENPP4 gene in the expression vector pET-28a
To obtain a mouse peritoneal macrophage cell prepar-
ation, female C57BL/6 mice, 10 week of age, were im-
munized intraperitoneally (i.p.) with 4 mg of BCG
(Chengdu Institute of Biological Products) three times
on days 2, 10, and 12. Three days after the last i.p. in-
jection, the mice were sacrificed and peritoneal cells
were collected. Adherent macrophages were collected
to prepare the total RNA and cDNA of ENPP4 by RT-
PCR [2, 3]. Briefly, PCR reactions were performed using
self-designed primer pairs: EF (5’-CGGGAATTCTCAG-
CACCTCGGTTACTT-3’) and ER (5’-AAACTCGAGAA-
GAATCGCAGCCACAGG-3’). All amplification reactions
consisted of an initial denaturation step at 94 °C for
5 min, 30 cycles of 94 °C denaturation for 1 min, 57 °C an-
nealing for 1 min, and 72 °C extension for 2 min, followed
by a final extension at 72 °C for 10 min using 2 units of
Taq DNA polymerase. The cDNA of ENPP4 was then
cloned to pET-28a to obtain the pET-28a–ENPP4 plasmid.
Expression and purification of recombinant ENPP4
protein in Escherichia coli
To determine the expression of the recombinant ENPP4
protein, Escherichia coli Rosetta (DE3) (Invitrogen)
transformed with pET-28a–ENPP4 plasmid DNA was
inoculated in a tube containing 10 mL of LB medium
supplemented with kanamycin and chloromycetin. The
tube was allowed to culture overnight at 37 °C in a shak-
ing incubator (180 rpm) until the culture reached an OD
of 0.6 when read at a wavelength of 600 nm. Protein ex-
pression was induced by the addition of 0.2, 0.4, 0.6, and
0.8 mM isopropyl βD-1-thiogalactopyranoside. After 6 h
of induction at 37 °C, the cells were collected by centri-
fugation for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE).
To obtain the recombinant ENPP4 protein, bacterial
cells were harvested by centrifugation at 4 °C and re-
suspended in PBS buffer. The bacterial pellets were
then mixed with 10 mmol/L MgSO4, 0.01 mg/mL
DNaseI, and 0.1 mg/mL lysis enzyme and left at 4 °C
for 20 min. After centrifugation, the bacterial pellets
were loaded with ice-cold lysis buffer (50 mmol/L Tris-
Cl, 0.1 mol/L NaCl, 5 mmol/L EDTA, 0.1 % NaN3,
0.5 % Triton X-100, pH 6.8) and sonicated at 1000 W
for 5 s with 10 s intervals for 160 cycles. The super-
natant was discarded, and the pellet (inclusion bodies)
containing the recombinant ENPP4 protein was sub-
jected to dilute renaturation and dialysis renaturation
and concentration. The purity of the extracted protein
was detected by SDS-PAGE.
Preparation of polyclonal antibodies and Western blot
analysis
Purified recombitant protein was used as the immuno-
gen. Approximately 100 μg of the fusion protein emulsi-
fied in complete Freund’s adjuvant was administered
during initial inoculation, and 50 μg of fusion protein
emulsified in incomplete Freund’s adjuvant was given
after 2 weeks. This procedure was repeated 5 times at
1 week intervals. Final rabbit serum was harvested after
immunization.
ENPP4 peptides were separated by SDS-PAGE and
electrotransferred onto the PVDF membrane. The mem-
brane was blocked with 3 % bovine serum albumin in
PBS for 2 h at room temperature. Subsequently, anti-
ENPP4 antibodies were added at a dilution of 1:1000
and incubated at room temperature for 1 h. After wash-
ing thrice for 15 min, IgG goat-anti-rabbit-HRP was
added and incubated for 1 h at room temperature. After
a final washing, the resulting signals were detected using
DAB (3,3-diaminobenzidine tetrahydrochloride).
Immunohistochemistry for ENPP4 detection in mouse tissues
Various mouse tissues (including heart, liver, kidney,
spleen, muscle, lung, intestine, uterus, and ovary) were
formalin-fixed at 4 °C overnight and then embedded in
paraffin and sectioned for histology. Immunohistochemi-
cal staining of serial sections was performed to detect
the expression and distribution of ENPP4. All samples
were incubated in 0.3 % H2O2 for 10 min at room
temperature to inactivate endogenous peroxidase. The
paraffinized sections were then incubated with anti-
ENPP4 primary antibody for 1 h at room temperature.
After washing, the sections were incubated with
peroxidase-conjugated goat anti rabbit IgG for 40 min.
After a final washing, the resulting signals were detected
using DAB and photographed with a microscope.
Tumoricidal effect of ENPP4 on MCA207 cells
BAM-mediated tumor cytotoxicity was determined with
and without anti-ENPP4 antibodies. Peritoneal macro-
phages were harvested from mice and fixed with 1 %
paraformaldehyde for 30 min at room temperature.
Afterward, 6 × 105 cells were incubated for 2 h with 5 μL
of anti-ENPP4 serum (previously prepared by our re-
search group) and 5 μL of control serum (from preim-
munized rabbit). The blocked cells were then washed
twice with RPMI 1640 medium, seeded into a 96-well
flat-bottom plate containing 1 × 104 MCA207 target
cells/well, and incubated for 48 h. The number of viable
tumor cells was determined by MTT (5 mg/mL, Sigma)
assay. The absorbance at 570 nm was recorded directly
using a microplate reader (Model 550, Bio-RAD).
Purified ENPP4 protein (prepared by our team) was
added to MCA207 (1 × 104 cells, cultured in 96-well
Yan et al. Lipids in Health and Disease  (2016) 15:19 Page 7 of 8
plates) at concentrations of 1, 10, 20, and 40 μg/mL, and
the cells were incubated for 48 h at 37 °C under a 5 %
CO2 atmosphere. The proliferation levels of MCA207
were detected by MTT assay.
Statistical analysis
Each experiment was repeated at least three times. Data
were expressed as mean ± SEM and analyzed by one-way
analysis of variance. P values < 0.05 (95 % confidence
level) were considered statistically significant.
Additional files
Additional file 1: Figure S1. The RMSD of ENPP4 during the 10 ns MD
simulation. (JPG 172 kb)
Additional file 2: Figure S2 a: The binding pocked of ENPP4
(calculated by CASTp, 2237.4 Å3); b: The binding pocket of ENPP1 (PDB Id
4GTX) (calculated by CASTp,. 1177.7 Å3). (JPG 223 kb)
Additional file 3: Figure S3. BCG increased the expression of ENPP4 in
the macrophages. (JPG 22 kb)
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